SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Citigroup Maintains Buy on Applied Therapeutics, Raises Price Target to $44

Citigroup maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $29 to $44.

Benzinga · 01/09/2020 16:37

Citigroup maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $29 to $44.